We examined TDP-43 immunoreactivity in control and FTD–GRN patient-derived iMGs to determine whether PGRN depletion in the human microglial-like cell model might represent critical aspects of FTD–TDP pathophysiology. This evidence concerns the gene TARDBP and frontotemporal dementia.